Measured Risk Portfolios’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
Other funds holding BMY
Measured Risk Portfolios's BMY Position: Q1 2025 in Review
Measured Risk Portfolios sold out of Bristol-Myers Squibb (BMY) in Q1 2025, closing a stake of 100 shares — an estimated $5.66K sold.
Measured Risk Portfolios first reported a position in BMY in Q4 2024 and held it in 1 quarter. The position peaked at $5.66K in Q4 2024. 2,478 funds tracked by Wall St. Rank hold BMY as of Q1 2025.
- Measured Risk Portfolios reported no remaining Bristol-Myers Squibb position as of Q1 2025 after selling out during the quarter.
- Measured Risk Portfolios sold 100 Bristol-Myers Squibb shares in Q1 2025, an estimated $5.66K.
- Measured Risk Portfolios first reported a position in Bristol-Myers Squibb in Q4 2024 and held it in 1 quarter.
- Measured Risk Portfolios's Bristol-Myers Squibb position peaked at $5.66K in Q4 2024.
- 2,478 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q1 2025.
Based on Measured Risk Portfolios's 13F filing for Q1 2025, filed 13 May 2025.